TCTR20240329004已完成4 期
Daily single-strength vs. thrice-weekly double-strength trimethoprim/ sulfamethoxazole for Pneumocystis jirovecii prophylaxis in kidney transplant recipients: A non-inferiority randomized control trial
/A0 个研究点目标入组 65 人开始时间: 2024年3月29日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 65
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. solid organ transplant recipient
排除标准
- •1. trimethoprim/sulfamethoxazole allergy
- •2. underlying Glucose-6-Phosphate Dehydrogenase deficiency
研究者
相似试验
已完成
3 期
Daily single-strength versus thrice-weekly double-strength trimethoprim/sulfamethoxazole for Pneumocystis jirovecii prophylaxis in solid organ transplant recipients: A randomized control trialTCTR20220720010Faculty of Medicine Ramathibodi Hospital200
已完成
2 期
Comparison of the effect of single and twice daily administration of ranitidine in relief of morning abdominal pain and nausea in childreabdominal pain and nausea.Unspecified abdominal painIRCT20171211037830N2Deputy of Research of Golestan University of Medical Sciences150
尚未招募
4 期
Prophylactic Therapy in HemophiliaCTRI/2018/08/015235Intramural research grant from UCMS
尚未招募
4 期
Glargine once versus twice dailyCTRI/2023/10/059275surbhi bharti
招募中
3 期
Comparison of Once- Versus Twice-Daily Administration of long-acting insulin Detemir in children with type 1 diabetesIRCT20181106041574N1Tehran University of Medical Sciences50